Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors
Molecules · 05.01.2023 · 28 (2) · 559
DOI: 10.3390/molecules28020559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 05.01.2023. Verfasst von Shoaib Khan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Hazara University, Mansehra 21120, Pakistan. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease is a major public brain condition that has resulted in many deaths, as revealed by the World Health Organization (WHO). Conventional Alzheimer’s treatments such as chemotherapy, surgery, and radiotherapy are not very effective and are usually associated with several adverse effects. Therefore, it is necessary to find a new therapeutic approach that completely treats Alzheimer’s disease without many side effects. In this research project, we report the synthesis and biological activities of some new thiazole-bearing sulfonamide analogs (1–21) as potent anti-Alzheimer’s agents. Suitable characterization techniques were employed, and the density functional theory (DFT) computational approach, as well as in-silico molecular modeling, has been employed to assess the electronic properties and anti-Alzheimer’s potency of the analogs. All analogs exhibited a varied degree of inhibitory potential, but analog 1 was found to have excellent potency (IC50 = 0.10 ± 0.05 µM for AChE) and (IC50 = 0.20 ± 0.050 µM for BuChE) as compared to the reference drug donepezil (IC50 = 2.16 ± 0.12 µM and 4.5 ± 0.11 µM). The structure-activity relationship was established, and it mainly depends upon the nature, position, number, and electron-donating/-withdrawing effects of the substituent/s on the phenyl rings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Hazara University, Mansehra 21120, Pakistan.
- Department of Chemistry, University of Okara, Okara 56130, Pakistan.
- Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
- Department of Zoology, Wildlife and Fisheries, University of Agriculture Faisalabad, Sub-Campus, Toba Tek Singh 36050, Pakistan.
- Department of Agronomy, Faculty of Agriculture and Environment, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.
- Department of Chemistry, University of Poonch, Rawalakot 12350, Pakistan.
ORCID-Profile: Shoaib Khan, Hayat Ullah, Muhammad Taha, Rashid Iqbal, Syed Adnan Ali Shah, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi
Zitieren
APA
Khan, S., Ullah, H., Taha, M., Rahim, F., Sarfraz, M., Iqbal, R., Iqbal, N., Hussain, R., Ali Shah, S. A., Ayub, K., Albalawi, M. A., Abdelaziz, M. A., Alatawi, F. S., & Khan, K. M. (2023). Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors. Molecules, 28(2), 559. https://doi.org/10.3390/molecules28020559
Vancouver
Khan S, Ullah H, Taha M, Rahim F, Sarfraz M, Iqbal R, et al. Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors. Molecules. 2023;28(2):559. doi:10.3390/molecules28020559
BibTeX
@article{Khan2023,
author = {Khan, Shoaib and Ullah, Hayat and Taha, Muhammad and Rahim, Fazal and Sarfraz, Maliha and Iqbal, Rashid and Iqbal, Naveed and Hussain, Rafaqat and Ali Shah, Syed Adnan and Ayub, Khurshid and Albalawi, Marzough Aziz and Abdelaziz, Mahmoud A and Alatawi, Fatema Suliman and Khan, Khalid Mohammed},
title = {Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {559},
doi = {10.3390/molecules28020559}
}
EUVIMED